Single-lobe living-donor lobar lung transplantation (SLDLLT) shows comparable 5- and 10-year survival to bilateral LDLLT, with retransplantation risk when chronic lung allograft dysfunction (CLAD) develops (2008–2021 cohort) - Vera Health News